QuidelOrtho (QDEL)
icon
搜索文档
QuidelOrtho (QDEL) - 2022 Q2 - Earnings Call Presentation
2022-08-05 05:09
| --- | |-------| | | | | | | | | Forward-Looking Statements Forward-Looking Statements: This presentation of QuidelOrtho Corporation ("QuidelOrtho" or the "Company") contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify these statements and other forward-looking statements in this presentation by words such as "may," "will," "would," "expect," "anticipate," "believe," "estimate," "plan," "intend," "continue," or similar words, exp ...
QuidelOrtho (QDEL) - 2022 Q1 - Earnings Call Transcript
2022-05-08 06:23
Ortho Clinical Diagnostics Holdings PLC (OCDX) Q1 2022 Earnings Conference Call May 4, 2022 4:30 PM ET Company Participants Bryan Brokmeier - Vice President, Investor Relations Chris Smith - Chairman and Chief Executive Officer Joseph Busky - Chief Financial Officer Operator Welcome to the Ortho Clinical Diagnostics First Quarter 2022 Earnings Conference Call and Webcast. At this time, all participants lines are in a listen-only mode. Please note this conference is being recorded. An audio replay of the con ...
QuidelOrtho (QDEL) - 2022 Q1 - Earnings Call Presentation
2022-05-05 15:24
| --- | --- | --- | --- | |--------------------------------------|----------------------|-------|-------| | | | | | | | | | | | | Earnings Results | | | | INVESTOR PRESENTATION (Nasdaq: OCDX) | 1Q 2022 May 04, 2022 | | | © Ortho Clinical Diagnostics 2022 Forward-Looking Statements This presentation and the oral remarks may contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forwa ...
Quidel Corporation (QDEL) Presents at ACC 2022 - Slideshow
2022-04-06 01:18
Quidel Corporation Raymond James March 2022 Copyright © 2022 Quidel Corporation. All rights reserved. Forward-Looking Statements and Additional Information Where You Can Find Additional Information In connection with the proposed business combination transaction among Quidel Corporation (the "Company"), Ortho Clinical Diagnostics Holdings plc ("Ortho") and Coronado Topco, Inc. ("Topco"), Topco has filed a registration statement on Form S-4 with the Securities and Exchange Commission (the "Commission") that ...
QuidelOrtho (QDEL) - 2021 Q4 - Earnings Call Transcript
2022-02-18 09:36
Quidel Corporation (NASDAQ:QDEL) Q4 2021 Earnings Conference Call February 17, 2022 5:00 PM ET Company Participants Ruben Argueta – Director of Investor Relations Doug Bryant – President and Chief Executive Officer Randy Steward – Chief Financial Officer Joe Busky – Chief Financial Officer, Ortho Clinical Diagnostics Holdings Chris Smith – Chairman and Chief Executive Officer, Ortho Clinical Diagnostics Holdings Rob Bujarski – Chief Operating Officer Conference Call Participants Tycho Peterson – JPMorgan Br ...
QuidelOrtho (QDEL) - 2021 Q3 - Earnings Call Transcript
2021-11-08 04:45
Ortho Clinical Diagnostics Holdings plc (OCDX) Q3 2021 Earnings Conference Call November 3, 2021 5:00 PM ET Company Participants Bryan Brokmeier - Vice President of Investor Relations Chris Smith - Chairman & Chief Executive Officer Joe Busky - Chief Financial Officer Mike Iskra - Executive Vice President of Commercial Excellence & Strategy Conference Call Participants Tycho Peterson - JP Morgan Vijay Kumar - ISI Derik De Bruin - Bank of America Matt Sykes - Goldman Sachs Patrick Donnelly - Citi Tejas Savan ...
Ortho Clinical Diagnostics Holdings (OCDX) Presents At H. C. Wainwright 23rd Annual Global Investment Conference - Slideshow
2021-09-17 03:48
Ortho Clinical Diagnostics H.C. Wainwright Annual Global Investment Conference (Nasdaq: OCDX) © Ortho Clinical Diagnostics 2021 Forward-Looking Statements This presentation and the oral remarks may contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements reflect, among other things, our current expectations and anticipated results of operations, all of ...
QuidelOrtho (QDEL) - 2021 Q2 - Earnings Call Presentation
2021-08-17 03:23
| --- | --- | --- | --- | --- | |-------|-------|-------|-------|-------| | | | | | | | | | | | | HIGHLY CONFIDENTIAL © Ortho Clinical Diagnostics 2021 Forward-Looking Statements This presentation and the oral remarks may contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements reflect, among other things, our current expectations and anticipated result ...
QuidelOrtho (QDEL) - 2021 Q2 - Earnings Call Transcript
2021-08-08 09:32
Ortho Clinical Diagnostics Holdings plc (OCDX) Q2 2021 Results Conference Call August 4, 2021 5:00 PM ET | --- | |------------------------------------------------------| | | | Company Participants | | Chris Smith - Chairman and CEO Joe Busky - CFO | | | | Conference Call Participants | | Vijay Kumar - ISI | | Tycho Peterson - JP Morgan | | Derik De Bruin - Bank of America | | Luke Sergott - Barclays | | Patrick Donnelly - Citi | | John Sourbeer - UBS | | Matt Sykes - Goldman Sachs Yi Chen - H.C. Wainwright ...